Literature DB >> 19882575

Ocular surface temperature in diabetic retinopathy: a pilot study by infrared thermography.

Andrea Sodi1, Barbara Giambene, Paolo Miranda, Giacomo Falaschi, Andrea Corvi, Ugo Menchini.   

Abstract

PURPOSE: To compare ocular surface temperature (OST) measures in patients with nonproliferative diabetic retinopathy (NPDR) and healthy controls.
METHODS: A total of 51 consecutive patients with different severity degrees of NPDR and 53 age- and gender-matched healthy volunteers were recruited. OST was evaluated by infrared thermography in five conjunctival (points 1, 2, 4, 5) and corneal (point 3) points.
RESULTS: In diabetic eyes, OST values were lower than in controls at all the studied points (p<0.001 at points 1, 2, 3, 4, and p=0.003 at point 5).
CONCLUSIONS: Ocular surface temperature measurements, by estimating ocular blood flow, may be helpful in the management of patients with diabetic retinopathy.

Entities:  

Mesh:

Year:  2009        PMID: 19882575     DOI: 10.1177/112067210901900617

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   1.922


  4 in total

1.  A novel image processing procedure for thermographic image analysis.

Authors:  Sara Matteoli; Davide Coppini; Andrea Corvi
Journal:  Med Biol Eng Comput       Date:  2018-03-14       Impact factor: 2.602

2.  Ocular surface temperature in age-related macular degeneration.

Authors:  Andrea Sodi; Sara Matteoli; Giovanni Giacomelli; Lucia Finocchio; Andrea Corvi; Ugo Menchini
Journal:  J Ophthalmol       Date:  2014-11-11       Impact factor: 1.909

3.  Cornea Thermography: Optimal Evaluation of the Outcome and the Resulting Reproducibility.

Authors:  Katarzyna Konieczka; Andreas Schoetzau; Simone Koch; Daniela Hauenstein; Josef Flammer
Journal:  Transl Vis Sci Technol       Date:  2018-06-07       Impact factor: 3.283

4.  Contact lenses for continuous corneal temperature monitoring.

Authors:  Rosalia Moreddu; Mohamed Elsherif; Haider Butt; Daniele Vigolo; Ali K Yetisen
Journal:  RSC Adv       Date:  2019-04-11       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.